Salute e Benessere

Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma…

The data demonstrate that uPARAP is strongly over-expressed in glioblastoma cells and that a uPARAP targeting ADC exhibits strong in vivo anti-tumor activity in a glioblastoma PDX model. Based on its differentiated expression profile and rapid internalization capabilities, uPARAP is an attractive novel target for the development of a uPARAP-targeting ADC in this hard-to-treat disease area with a high unmet medical need due to limited treatment options. The data demonstrate that uPARAP is...
PR Newswire
04/04/2024

Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)

Right to participate and registration Right to participate and registration (A) Participation at the meeting venue A person who wishes to attend the meeting venue in person or by proxy must If the shareholder is represented by proxy, a written and dated power of attorney signed by the shareholder shall be issued for the proxy. Proxy forms are available at the company's websitewww.sobi.com. If the power of attorney has been issued by a legal entity, a registration certificate or...
PR Newswire
04/04/2024

Pharming Group announces the 2024 Annual General Meeting of Shareholders

Leiden, The Netherlands, April 4, 2024:Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Company's 2024 Annual General Meeting of Shareholders (the “AGM”) will be held on Tuesday, May 21, 2024 at 14:30 CEST. The Notice to Convene, Explanatory Notes, Proxy and other meeting documents for the AGM can be found on the Company's website under Investors/Shareholder Meetings.The agenda of the AGM includes the reappointment of Ms...
Nasdaq GlobeNewswire
04/04/2024

Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole…

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, April 04, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the US Food and Drug Administration (FDA) approved ZEVTERA ®(ceftobiprole medocaril sodium for injection), for the treatment of adult patients withStaphylococcus aureusbloodstream infections...
Nasdaq GlobeNewswire
04/04/2024

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F

Leiden, The Netherlands, April 4, 2024:Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the filing of its Annual Report for the year ended December 31, 2023 (the “Period”). The Annual Report is available under Investors/Financial documents on the Pharming.com website. The Company also announces the filing of its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission (SEC) for the Period. The 2023 Annual Report on...
Nasdaq GlobeNewswire
04/04/2024

Ultimovacs to Present Poster at the American Association for Cancer Research…

Oslo, April 4, 2024:Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announces that the data from the TENDU-101 study in patients with relapse after primary radical prostatectomy (NCT04701021) will be presented in a poster at the 2024 American Association for Cancer Research (AACR), taking place April 5-10, 2024, in San Diego, CA.Additionally, a poster with results related to the Phase I study in prostate...
Nasdaq GlobeNewswire
04/04/2024

Ad Hoc Press Release - Regulated Information

Disclosure Disclosure The information was submitted for publication, through the contact persons set out below, at07:00 CESTon4 April 2024. Further information is available on investors.firmenich.com and dsm-firmenich.com. ENDS Contacts Email: ingvild.van.lysebetten@dsm-firmenich.com Email: robin.roothans@dsm-firmenich.com About Firmenich Firmenich International SA announced on9 May 2023the completion of its merger with DSM to establish...
PR Newswire
04/04/2024

PolTREG identifies promising efficacy biomarker for Type-1 diabetes in patients…

New biomarker may facilitate monitoring T1D patients' healthIncrease in PD-1+ T-cells correlated with therapeutic response and less insulin use Gdańsk, Poland – 4 April 2024– PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces it has published data inInternational Immunopharmacologywhich suggest that PD-1+ T-cells are a dependable biomarker for efficacy in pediatric...
Nasdaq GlobeNewswire
04/04/2024

Chitosan Market Projected to Reach $4.07 billion by 2030 - Exclusive Report by…

Chitosan is a versatile polysaccharide derived from a unique alkaline treatment process, and deacetylation is derived from the chitin in crustacean exoskeletons. Its properties, majorly biocompatibility, biodegradability, and antimicrobial effects, are garnering attention, fueling its demand across various sectors such as pharmaceuticals, food & beverages, cosmetics, agriculture, and water treatment. The search for biodegradable alternatives has never been more pressing, spotlighting…
PR Newswire
04/04/2024

Malic Acid Market Projected to Reach $1,090.84 million by 2030 - Exclusive…

Malic acid, known as hydroxybutanedioic acid, is revolutionizing industries, including food & beverage, pharmaceuticals, and cosmetics, owing to its natural presence in fruits and vegetables, most notably apples, and its pivotal role in the body's energy production cycle. Widely synthesized for its ability to enhance flavors and preserve product freshness, malic acid is acclaimed for health benefits such as improving skin texture and aiding muscle recovery in chronic conditions. As…
PR Newswire
04/04/2024

Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense…

Key Takeaways from the Cough in Idiopathic Pulmonary Fibrosis Market Report Key Takeaways from the Cough in Idiopathic Pulmonary Fibrosis Market Report Discover which therapies are expected to grab the major cough in idiopathic pulmonary fibrosis market share @Cough in Idiopathic Pulmonary Fibrosis Market Report Cough in Idiopathic Pulmonary Fibrosis Overview Chronic cough is a common occurrence in idiopathic pulmonary fibrosis (IPF), frequently emerging as the initial sign...
PR Newswire
03/04/2024

Inventiva announces filing of its 2023 Universal Registration Document and 2023…

Daix (France), Long Island City (New York, United States), April 3, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced that it had filed its 2023 Universal Registration...
Nasdaq GlobeNewswire
03/04/2024

The US Medical Kiosks Market is Set to Reach $4.43 Billion by 2029, the Arrival…

The U.S. Medical Kiosks Market Report Scope The U.S. Medical Kiosks Market Report Scope The U.S. medical kiosk market report contains exclusive data on 39 vendors. The U.S. medical kiosk market is highly fragmented, with many local and international players. The leading medical kiosk market vendors are Fabcon, Meridian, Verifone, Xiphias Software Technologies, and Redyref. The competition among these players is intense. The rapidly changing technological environment can adversely...
PR Newswire
03/04/2024

iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and…

The wearable accessory ensures easy, quick, and comfortable image acquisition. Popular for its portability, patient comfort, and precise diagnosis, it can be used in any in-patient or out-patient setting, including hospitals, radiology centers, or even delivering care at home. Healthcare personnel (HCP) can access and view the images on any web-enabled device regardless of location, where they may interact with the images and access radial, coronal, sagittal, and transversal views of tissue to…
PR Newswire
03/04/2024

AB Science announces that Health Canada has granted eligibility for…

PRESS RELEASEAB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED ELIGIBILITY FOR RECONSIDERATION REQUEST FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSISParis, 3 April, 2024, 6pm CETAB Science SA(Euronext - FR0010557264 - AB) today announces that Health Canada has granted eligibility for reconsideration request for masitinib in amyotrophic lateral sclerosis (ALS). The reconsideration process will re-examine, with new assessors, the decision based on information that was included...
Nasdaq GlobeNewswire
03/04/2024

Transparency Notifications from Shareholders

PRESS RELEASE REGULATED INFORMATION 3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table…
Nasdaq GlobeNewswire
03/04/2024

Diagnostic Contract Manufacturing Market Worth $44.9 billion |…

Browse in-depth TOC on "Diagnostic Contract Manufacturing Market" Browse in-depth TOC on "Diagnostic Contract Manufacturing Market" 183 - Tables 37 - Figures 218 - Pages Diagnostic Contract Manufacturing Market Scope: The IVD Consumables segment is expected to account for the largest share in 2022. The increased accessibility and demand for reagents & kits and the rising number of IVD tests performed are the key factors driving the growth of this segment. The IVD...
PR Newswire
03/04/2024

Lipids with potential health benefits in herbal teas

Lipids are a diverse collection of natural substances that share the property of being insoluble in water. They include all of the fats and oils that are common constituents of many foods, but they have generally not been examined as significant components of teas. Lipids are a diverse collection of natural substances that share the property of being insoluble in water. They include all of the fats and oils that are common constituents of many foods, but they have generally not been examined…
PR Newswire
03/04/2024

Innovation in Cans Packaging with Ecocap's

Sara Mei
03/04/2024

Major shareholder announcement – Swedbank Robur Fonder AB

ANNOUNCEMENT NO. 259Major shareholder announcementMajor shareholder announcement – Swedbank Robur Fonder AB Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Swedbank Robur Fonder AB has informed ChemoMetec A/S that Swedbank Robur Fonder AB on 2 April 2024, decreased its holding of shares and voting rights to below 5% of the total share capital and voting rights in ChemoMetec A/S.Additional information Niels Høy Nielsen,...
Nasdaq GlobeNewswire
03/04/2024

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "IR Spectroscopy Market" 130 – Tables90 – Figures240 – Pages Browse in-depth TOC on "IR Spectroscopy Market" 130 – Tables 90 – Figures 240 – Pages IR Spectroscopy Market Report Scope: By End-user Industry: Healthcare and Pharmaceuticals segment to account for the largest market share in the forecasted year. The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029. IR spectroscopy...
PR Newswire
03/04/2024

RevitaLash® Advanced Eyelash Conditioner Makes Triumphant Return to California…

"As a family-owned business, we are celebrating our contributions to this industry, and that starts with our best-selling RevitaLash Advanced Eyelash Conditioner," said Dr. Michael Brinkenhoff, Founder and CEO of RevitaLash® Cosmetics. "I created the original RevitaLash eyelash conditioner for my late wife, Gayle. She proved to all of us that it is possible to live a full, meaningful, passionate life, even in the face of a metastatic breast cancer diagnosis. She continues to be…
PR Newswire
03/04/2024

ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9…

To access the conference call, please registerhere. Registrants will receive the dial-in number and unique PIN. It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A live webcast of the call will be available under “Events and Presentations” in the Investors section of the ADC Therapeutics website atir.adctherapeutics.com. The archived webcast will be available for 30 days following the call. About ADC Therapeutics ADC Therapeutics...
Nasdaq GlobeNewswire
03/04/2024

Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will host an audio call with a brief market update at 12:15 pm GMT / 08:15 am EDT. Anil Okay, Chief Commercial Officer, will be providing the update. Information on how to access the webcast is posted on Alvotech's investor website at https://investors.alvotech.com/events/event-details/market-update-2024-04-03 . The...
Nasdaq GlobeNewswire
03/04/2024
Altri  Comunicati